BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schwarz RE. Current status of management of malignant disease: current management of gastric cancer. J Gastrointest Surg. 2015;19:782-788. [PMID: 25591828 DOI: 10.1007/s11605-014-2707-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Toneto MG, Viola L. CURRENT STATUS OF THE MULTIDISCIPLINARY TREATMENT OF GASTRIC ADENOCARCINOMA. Arq Bras Cir Dig 2018;31:e1373. [PMID: 29972401 DOI: 10.1590/0102-672020180001e1373] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
2 Pandit N, Singh H, Jaiswal LS. Diagnosing Gastric Cancer in Chest X-ray. Indian J Surg 2018;80:192-3. [PMID: 29915488 DOI: 10.1007/s12262-018-1725-4] [Reference Citation Analysis]
3 Fugazzola P, Ansaloni L, Sartelli M, Catena F, Cicuttin E, Leandro G, De' Angelis GL, Gaiani F, Di Mario F, Tomasoni M, Coccolini F. Advanced gastric cancer: the value of surgery. Acta Biomed 2018;89:110-6. [PMID: 30561428 DOI: 10.23750/abm.v89i8-S.7897] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
4 Fiori E, Sterpetti AV, De Cesare A, Lamazza A. Factors Leading to Improved Results for Endoscopic Stenting for Metastatic Antropyloric Adenocarcinoma. A Comparison with Gastrojejunostomy. J Gastrointest Surg 2016;20:1802-6. [PMID: 27510331 DOI: 10.1007/s11605-016-3236-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
5 Luo T, Chen W, Wang L, Zhao H. CA-125 is a potential biomarker to predict surgically incurable gastric and cardia cancer: A retrospective study. Medicine (Baltimore). 2016;95:e5297. [PMID: 28002320 DOI: 10.1097/md.0000000000005297] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Okugawa Y, Toiyama Y, Shigeyasu K, Yamamoto A, Shigemori T, Yin C, Ichikawa T, Yasuda H, Fujikawa H, Yoshiyama S, Hiro J, Ohi M, Araki T, Kusunoki M, Goel A. Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer. J Transl Med 2018;16:366. [PMID: 30563560 DOI: 10.1186/s12967-018-1740-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
7 Coccolini F, Montori G, Ceresoli M, Cima S, Valli MC, Nita GE, Heyer A, Catena F, Ansaloni L. Advanced gastric cancer: What we know and what we still have to learn. World J Gastroenterol 2016; 22(3): 1139-1159 [PMID: 26811653 DOI: 10.3748/wjg.v22.i3.1139] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
8 Schwarz RE. Clinical trends and effects on quality metrics for surgical gastroesophageal cancer care. Transl Gastroenterol Hepatol 2018;3:43. [PMID: 30148228 DOI: 10.21037/tgh.2018.06.07] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Chen XL, Su LL. Sinomenine inhibits proliferation, migration, and invasion of gastric cancer cells via MALAT1 to regulate miR-141: Clinical implications. Shijie Huaren Xiaohua Zazhi 2019; 27(6): 352-360 [DOI: 10.11569/wcjd.v27.i6.352] [Reference Citation Analysis]
10 Huntington CR, Walsh K, Han Y, Salo J, Hill J. National Trends in Utilization of Endoscopic Ultrasound for Gastric Cancer: a SEER-Medicare Study. J Gastrointest Surg. 2016;20:154-163; discussion 163-164. [PMID: 26553265 DOI: 10.1007/s11605-015-2988-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Søreide JA. Therapeutic Approaches to Gastric Hepatoid Adenocarcinoma: Current Perspectives. Ther Clin Risk Manag 2019;15:1469-77. [PMID: 31920320 DOI: 10.2147/TCRM.S204303] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
12 Pang W, Lou N, Jin C, Hu C, Arvine C, Zhu G, Shen X. Combination of preoperative platelet/lymphocyte and neutrophil/lymphocyte rates and tumor-related factors to predict lymph node metastasis in patients with gastric cancer. Eur J Gastroenterol Hepatol 2016;28:493-502. [PMID: 26854795 DOI: 10.1097/MEG.0000000000000563] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
13 Gao CL, Sun R, Li DH, Gong F. PIWI-like protein 1 upregulation promotes gastric cancer invasion and metastasis. Onco Targets Ther 2018;11:8783-9. [PMID: 30584336 DOI: 10.2147/OTT.S186827] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
14 Nishizaki D, Ganeko R, Hoshino N, Hida K, Obama K, Furukawa TA, Sakai Y, Watanabe N. Roux-en-Y versus Billroth-I reconstruction after distal gastrectomy for gastric cancer. Cochrane Database Syst Rev 2021;9:CD012998. [PMID: 34523717 DOI: 10.1002/14651858.CD012998.pub2] [Reference Citation Analysis]
15 Chin JY, Hong TS. Gastric Cancer. In: Small W, Tarbell NJ, Yao M, editors. Clinical Radiation Oncology. Hoboken: John Wiley & Sons, Inc.; 2017. pp. 397-408. [DOI: 10.1002/9781119341154.ch21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
16 Ciesielski M, Kruszewski WJ, Walczak J, Szajewski M, Szefel J, Wydra J, Buczek T, Czerepko M. Analysis of postoperative morbidity and mortality following surgery for gastric cancer. Surgeon volume as the most significant prognostic factor. Prz Gastroenterol 2017;12:215-21. [PMID: 29123584 DOI: 10.5114/pg.2017.70475] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
17 Liu JZ, Hu YL, Feng Y, Guo YB, Liu YF, Yang JL, Mao QS, Xue WJ. Rafoxanide promotes apoptosis and autophagy of gastric cancer cells by suppressing PI3K /Akt/mTOR pathway. Exp Cell Res 2019;385:111691. [PMID: 31678170 DOI: 10.1016/j.yexcr.2019.111691] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
18 Ojima T, Nakamori M, Nakamura M, Katsuda M, Hayata K, Yamaue H. Laparoscopic Gastrojejunostomy for Patients with Unresectable Gastric Cancer with Gastric Outlet Obstruction. J Gastrointest Surg 2017;21:1220-5. [DOI: 10.1007/s11605-017-3387-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
19 Fiorica F, Trovò M, Ottaiano A, Nasti G, Carandina I, Marzola M, De Paoli P, Berretta M. Can the addition of radiotherapy postoperatively increase clinical outcome of patients with gastric cancer? A systematic review of the literature and meta-analysis. Oncotarget 2018;9:10734-44. [PMID: 29535839 DOI: 10.18632/oncotarget.23754] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
20 Minarich MJ, Schwarz RE. A Simplified Two-Step Technique for Extended Lymphadenectomy During Resection of Gastroesophageal Malignancy: Early Results Compared to En Bloc Dissection. J Gastrointest Surg 2019;23:393-401. [PMID: 30603860 DOI: 10.1007/s11605-018-4056-7] [Reference Citation Analysis]
21 Zhenzhen LI, Lanting Z, Lihong Z, Juan X, Zhengjiang C. [Single nucleotide polymorphism of rs28416520 in Piwil1 gene promoter region is associated with an increased risk of gastric cancer]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:1373-9. [PMID: 33118502 DOI: 10.12122/j.issn.1673-4254.2020.10.01] [Reference Citation Analysis]
22 Pan D, Chen H, Li LQ, Li ZF. Effect of Splenectomy Combined with Resection for Gastric Carcinoma on Patient Prognosis. Med Sci Monit 2016;22:4205-9. [PMID: 27816984 DOI: 10.12659/msm.897842] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]